Skip to main content
logo
MARX Biotech Co., Ltd. (TPEX:7731)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
4.580
-0.330 (-6.72%)
Jul 14, 2025, 1:58 PM CST

MARX Biotech Cash Flow Statement

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
 FY 2024 FY 2023 FY 2022 FY 2021
Period Ending
 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-96.83-12.922.834.43
Depreciation & Amortization
17.434.571.95-
Other Amortization
0.540.02--
Loss (Gain) From Sale of Assets
--0.1-
Loss (Gain) on Equity Investments
----4.97
Provision & Write-off of Bad Debts
7.612.890.99-
Other Operating Activities
-1.11-5.82-2.04-0.14
Change in Accounts Receivable
-26.77-40.845.04-
Change in Inventory
-84.92-6.65-2.98-
Change in Accounts Payable
65.063.13-1.050.89
Change in Unearned Revenue
10.3414.82--
Change in Other Net Operating Assets
1.4523.666.590.11
Operating Cash Flow
-107.18-17.1311.440.31
Operating Cash Flow Growth
--3566.35%-
Capital Expenditures
-206-1.04-0.7-
Sale of Property, Plant & Equipment
0.24---
Cash Acquisitions
-67.67-72.390.18-
Sale (Purchase) of Intangibles
-12.56-0.7--
Investment in Securities
-3.5---
Other Investing Activities
3.01-0.97-0.28-0.05
Investing Cash Flow
-286.48-75.1-0.79-0.05
Short-Term Debt Issued
98-10-
Long-Term Debt Issued
170.31---
Total Debt Issued
268.31-10-
Short-Term Debt Repaid
--25.99--
Long-Term Debt Repaid
-2.81-1.85-1.7-
Total Debt Repaid
-2.81-27.85-1.7-
Net Debt Issued (Repaid)
265.5-27.858.3-
Issuance of Common Stock
50251.76--
Common Dividends Paid
--6.59-7.35-
Financing Cash Flow
315.5217.330.95-
Net Cash Flow
-78.16125.111.60.27
Free Cash Flow
-313.18-18.1710.740.31
Free Cash Flow Growth
--3343.27%-
Free Cash Flow Margin
-50.66%-6.27%9.71%-
Free Cash Flow Per Share
-0.63-0.060.030.01
Cash Interest Paid
2.210.370.11-
Cash Income Tax Paid
0.084.654.12-
Levered Free Cash Flow
-292.53-58.58-38.72-
Unlevered Free Cash Flow
-291.14-58.34-38.65-
Change in Net Working Capital
37.4350.6440.46-
Source: S&P Global Market Intelligence. Standard template. Financial Sources.